BridgeMD
New treatment option for Multiple Cancers
Official title HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG
ClinicalTrials.gov ID: NCT07295171
What this study is testing
- What it's testing
- Typically, PET scans involve an IV injection of 18F-FDG that helps identify cancer. Patients are scanned 60 minutes after injecting 18F-FDG.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Age ≥19 years
- Participants who have received a standard of care [18F]FDG PET/CT and are willing to undergo a study specific oral [18F]FDG PET/CT within 2 weeks.
You likely can't join if
- Participant Inclusion Criteria
- Age ≥19 years
- Participants who have received a standard of care [18F]FDG PET/CT and are willing to undergo a study specific oral [18F]FDG PET/CT within 2 weeks...
- Pregnant or breast-feeding
- Medically unstable (e.g., acute illness, unstable vital signs)
- Urinary incontinence/catheter.
See the full eligibility criteria
- Age ≥19 years
- Participants who have received a standard of care [18F]FDG PET/CT and are willing to undergo a study specific oral [18F]FDG PET/CT within 2 weeks.
- Participant Inclusion Criteria
- Age ≥19 years
- Participants who have received a standard of care [18F]FDG PET/CT and are willing to undergo a study specific oral [18F]FDG PET/CT within 2 weeks. Participant Exclusion Criteria
- Pregnant or breast-feeding
- Medically unstable (e.g., acute illness, unstable vital signs)
- Urinary incontinence/catheter.
- Immobile, frail or vulnerable patients who cannot leave the department and would require an uptake room in any case.
- Patients whose fasting blood sugar at the SOC PET was \>11.0 mmol/l
- Unable to swallow.
- Patients with nasogastric tubes, percutaneous gastrostomy or other non-anatomical routes for nutrition.
- Unable to lie flat for 1h (subset of participants - first 5 participants only).
- Claustrophobia requiring medication.
- Undergoing active treatment or assessment of an upper digestive tract tumor (stomach/esophagus)
- Unable to provide written consent
- Patients receiving biguanide anti-hyperglycemic agents (e.g. Metformin).
- Insulin dependent diabetics.
The study team makes the final eligibility decision.
Where it's taking place
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vancouver, British Columbia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.